MMP9 Rabbit Polyclonal Antibody
Other products for "MMP9"
Specifications
| Product Data | |
| Applications | WB |
| Recommended Dilution | WB: 0.5-4 ug/ml, IP: 4-8ug/ml, IHC: 20-40 ug/ml |
| Reactivities | Rat |
| Host | Rabbit |
| Isotype | IgG |
| Clonality | Polyclonal |
| Immunogen | E. coli-expressed active rat 92-kDa type IV collagenase |
| Formulation | 100 µg (0.5 mg/ml) affinity purified rabbit anti-rat MMP-9 polyclonal antibody in phosphate buffered saline (PBS), pH 7.2, containing 50% glycerol, 1% BSA, 0.02% thimerosal. |
| Concentration | lot specific |
| Purification | Affinity purified |
| Storage | Store at -20°C as received. |
| Stability | Stable for 12 months from date of receipt. |
| Gene Name | matrix metallopeptidase 9 |
| Database Link | |
| Background | The mammalian Matrix metalloproteinases (MMPs) degrade extracellular matrix in physiological and pathological processes. After cleavage of a single peptide domain of about 20 amino acids, the MMPs are secreted in latent forms. Upon activation, the N-terminal propeptide domain is cleaved to generate the active forms of MMP. MMP-9 (92 kDa type IV collagenase, Gelatinase-B) contains the basic structure of propeptide, catalytic, and hemopexin domains. It is an important proteinase in tissue remodeling. |
| Synonyms | CLG4B; GELB; MANDP2; MMP-9 |
| Reference Data | |
| Protein Families | Druggable Genome, Protease |
| Protein Pathways | Bladder cancer, Leukocyte transendothelial migration, Pathways in cancer |
Documents
| Product Manuals |
| FAQs |
{0} Product Review(s)
0 Product Review(s)
Submit review
Be the first one to submit a review
Product Citations
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen
complexities in the preparation of your product. International customers may expect an additional 1-2 weeks
in shipping.
Germany
Japan
United Kingdom
China